Interactive Transcript
0:00
You here is a 15-year-old female patient.
0:04
who presented with headaches.
0:06
And this is the baseline study which showed a
0:10
tumor in the left thalamus, as you can see,
0:14
causing slight mass effect on the
0:15
posterior third ventricle.
0:17
The tumor does show a little bit of
0:21
areas of patchy enhancement,
0:24
and also has some increased cellularity as
0:30
seen on the diffusion scans over here.
0:34
As I mentioned earlier,
0:37
majority of these tumors in either midline or
0:40
para midline location, in a younger patient,
0:43
we should be worried about H3K27
0:47
mutant diffuse midline gliomas.
0:50
And this is what happens to this patient.
0:52
Within six weeks,
0:53
the follow-up MRI shows that the tumor actually is
0:56
increasing rather quickly.
0:58
Within six weeks,
0:59
the tumor has increased in size.
1:01
There are new areas of enhancement developing in this tumor.
1:05
At this time,
1:06
the patient underwent surgery and was proven
1:09
to be H3K27 mutant glioma.
1:13
The important thing in these cases, as we all know now,
1:18
that these tumors are very aggressive tumors
1:22
and they can progress rather quickly.
1:25
And this is what happens classically to these patients.
1:30
This is a scan done a year later.
1:33
So one-year follow-up and you can see the tumor is
1:37
actually now spreading through the left meningeal route.
1:41
There is spread within the ventricle,
1:43
there is subependymal tumor spread, multifocal disease.
1:47
And this is, again, a bad tumor and has a poor prognosis.
1:53
This unfortunate 15-year-old girl ended up dying from
1:58
this tumor within 15 months after the initial diagnosis,
2:04
as expected for these very aggressive tumors.
© 2025 Medality. All Rights Reserved.